rs121913246

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5

The NM_000245.4(MET):ā€‹c.3689A>Gā€‹(p.Tyr1230Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1230D) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MET
NM_000245.4 missense

Scores

10
7
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1

Conservation

PhyloP100: 5.01
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PM1
In a turn (size 3) in uniprot entity MET_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000245.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.873
PP5
Variant 7-116783360-A-G is Pathogenic according to our data. Variant chr7-116783360-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 13885.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=2}. Variant chr7-116783360-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
METNM_000245.4 linkuse as main transcriptc.3689A>G p.Tyr1230Cys missense_variant 19/21 ENST00000397752.8 NP_000236.2 P08581-1A0A024R759
METNM_001127500.3 linkuse as main transcriptc.3743A>G p.Tyr1248Cys missense_variant 19/21 NP_001120972.1 P08581-2A0A024R728
METNM_001324402.2 linkuse as main transcriptc.2399A>G p.Tyr800Cys missense_variant 18/20 NP_001311331.1 B4DLF5
METXM_011516223.2 linkuse as main transcriptc.3746A>G p.Tyr1249Cys missense_variant 20/22 XP_011514525.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
METENST00000397752.8 linkuse as main transcriptc.3689A>G p.Tyr1230Cys missense_variant 19/211 NM_000245.4 ENSP00000380860.3 P08581-1
METENST00000318493.11 linkuse as main transcriptc.3743A>G p.Tyr1248Cys missense_variant 19/211 ENSP00000317272.6 P08581-2
METENST00000436117.3 linkuse as main transcriptn.*1294A>G non_coding_transcript_exon_variant 18/201 ENSP00000410980.2 P08581-3
METENST00000436117.3 linkuse as main transcriptn.*1294A>G 3_prime_UTR_variant 18/201 ENSP00000410980.2 P08581-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1461828
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727220
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Papillary renal cell carcinoma type 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Mar 02, 2023This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 9140397, 34882875]. Functional studies indicate this variant impacts protein function [PMID: 9326629, 9826708, 10498872]. -
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 1997- -
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsJun 29, 2021The p.Y1248C variant (also known as c.3743A>G), located in coding exon 18 of the MET gene, results from an A to G substitution at nucleotide position 3743. The tyrosine at codon 1248 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant is reported in an individual with bilateral papillary renal cell carcinoma and gastric cancer (Schmidt L et al. Nat Genet, 1997 May;16:68-73). Functional studies indicate that the p.Y1248C alteration increases tyrosine kinase activity and confers cell transformation properties (Jeffers M et al. Proc Natl Acad Sci U S A, 1997 Oct;94:11445-50). Based on structural analysis, this variant is located in the tyrosine kinase domain and is mildly destabilizing to the local structure (Yuan H et al. Eur J Med Chem, 2018 Jan;143:491-502; Ambry internal data). This amino acid position is well conserved in available vertebrate species.This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Renal cell carcinoma Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 23, 2021This variant has been observed in an individual with bilateral papillary renal carcinoma, stomach cancer, and rectal cancer (PMID: 9140397). ClinVar contains an entry for this variant (Variation ID: 13885). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this variant affects MET protein function (PMID: 9826708). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with cysteine at codon 1248 of the MET protein (p.Tyr1248Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
D;.
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.70
T;T
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.87
D;D
MetaSVM
Uncertain
0.60
D
MutationAssessor
Uncertain
2.6
M;.
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-4.6
D;D
REVEL
Pathogenic
0.90
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;D
Vest4
0.83
MutPred
0.68
Loss of phosphorylation at Y1230 (P = 0.0464);.;
MVP
0.95
MPC
2.1
ClinPred
1.0
D
GERP RS
5.5
Varity_R
0.95
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121913246; hg19: chr7-116423414; COSMIC: COSV59257466; API